SINGHE HOSPITALS PLC (SINH.N0000)

Singhe Hospitals PLC is a private hospital engaged in providing laboratory and other related services. The Company is a tertiary care hospital with approximately 50 beds to accommodate patients with a range of medical specialties available across the day. It offers various services, which include around the clock outpatient department service, multi specialist consultants, around the clock radiology facility, around the clock pharmacy, intensive care unit, around the clock laboratory, dental unit, cardiac unit, around the clock ambulance service, ultrasound scanning, emergency treatment unit and patient parking facility. Its cardiac unit is equipped to diagnose cardiac anomalies. It also performs cataract and other eye surgeries. Its emergency unit consists of the ambulance, home nursing unit, emergency treatment unit and the intensive care unit. The Company has an endoscopy system, which can produce clear images for diagnosis of the patient. It operates in Ratnapura district.

asset value is around 1.30 but sold to the public at a premium of rs 2.50 what do u guys think of this ! i personally feels its rubbish

dont get caught this now ! 1.00-.50 cents may worth ... unless I dont wont to get involve

if you buy this share , They will give you a gift voucher to spend at the hospital for treatment

If any one has a prospect, please forward to me guys.

@Teller wrote:If any one has a prospect, please forward to me guys.

http://cse.lk/upcoming_listings.do

CSE site slow today?

Thanks keeper,i just download the prospect,I got this ipo news three weeks before and want to study.

The ongoing IPO of Singhe Hospitals is experiencing slow pick up given bearish sentiments on equities whilst the management expressed confidence that performance had improved with a likelihood of dividend next year.
The Initial Public Offering of 25% stake or 100 million shares at Rs. 2.50 each officially opened on 12 March. As of 19 March, Singhe Hospital had received 428 applications requesting for 17.4 million shares worth Rs. 43.5 million. The company is seeking a listing on the Diri Savi Board.
Singhe Hospitals Managing Director Navinda Weerasinghe said that the company had achieved its budget targets for 2014/15 and would continue to improve performance from the new financial year 2015/16 onwards with capital infusion from the IPO.
“We firmly believe in paying dividends to the investors with better profits generated from the IPO proceeds. This is in turn expected to increase our bottom-line. As such, the IPO investors will be able to reap benefits from dividends and increase in earnings,” Weerasinghe told the Daily FT.
The assurance comes on the back of losses reported for FY2014.
Singhe Hospitals posted revenue of Rs. 164 million as at 31 March 2014, up from Rs. 33.3 million in 2013. The company incurred finance costs of Rs. 51.9 million, up from a previous Rs. 50.6 million leading to a Rs. 131.6 million loss for the year, as compared with a loss of Rs. 107.9 million in 2013. Notably total comprehensive income for the year declined sharply to Rs. 37.1 million boosted significantly by a Rs. 94.5 million gain on revaluation of land and building in 2014. Basic loss per share stood at Rs. 4.69, against a previous Rs. 7.19 per share.
Of the Rs. 250 million IPO, Rs. 140 million will be used to partially settle the loans obtained from Bank of Ceylon and Rs. 30 million to settle the Bank Overdraft facility. This will enhance earnings per share and the net asset value of the company with 100% savings due to tax-free BOI project.
Balance funds will be directed towards the purchase of medical equipment, including new laparoscopy and mammography machines, in addition to the planned expansion of lab facilities, the establishment of an eye surgical unit, construction of a new car park and the purchase of fresh pharmaceutical and lab stocks.
As per the share valuation prepared by B.R. De Silva & Co. Chartered Accountants included in the prospectus for prospective investors, free cash flow valuation stood at Rs. 2.59 per share whilst the Price to Book value valuation stood at Rs. 1.73 per share.
Situated in the heart of Ratnapura, Singhe Hospital is a BOI-approved project started in December 2009 and enjoys a five-year tax holiday. The first private hospital to be established in the Sabaragamuwa District, Singhe Hospital reportedly records 15,000-20,000 patient visits monthly.
Navinda is the son of Chairman A.M Weerasinghe and was educated in the US, where he specialised in Business Management. He is personally steering the hospital with the guidance of Weerasinghe Sr. and the Board of Directors. He firmly believes in developing an organisation to a greater profitability and providing a return to the investors from day one.

First with an IPO in 2015, Singhe Hospitals Ltd. will debut today on the Colombo Stock Exchange.
The company managed to conclude its Rs. 250 million IPO using the full quota of days in March despite bearish sentiments. It offered 25% stake or 100 million shares at Rs. 2.50 each. The Issue opened for the public on 12 March and closed on 30 March.
The IPO drew 497 applications requesting 107 million shares worth Rs. 267.4 million. The basis of allotment was 100% allocation up to eight million shares applied and a minimum of eight million shares plus 95.05% of the balance shares applied if original application is for over eight million shares.

 
Security code assigned is SINH-N-0000 with 398.225 million shares listed.
Situated in the heart of Ratnapura, Singhe Hospital is a BOI-approved project started in December 2009 and enjoys a five-year tax holiday. The first private hospital to be established in the Sabaragamuwa District, Singhe Hospital reportedly records 15,000-20,000 patient visits monthly.
Of the Rs. 250 million IPO, Rs. 140 million will be used to partially settle the loans obtained from Bank of Ceylon and Rs. 30 million to settle the bank overdraft facility. This will enhance earnings per share and the net asset value of the company with 100% savings due to tax-free BOI project.
Balance funds will be directed towards the purchase of medical equipment, including new laparoscopy and mammography machines, in addition to the planned expansion of lab facilities, the establishment of an eye surgical unit, construction of a new car park and the purchase of fresh pharmaceutical and lab stocks.

 
As per the share valuation prepared by B.R. De Silva & Co. Chartered Accountants included in the prospectus for prospective investors, free cash flow valuation stood at Rs. 2.59 per share whilst the price to book value valuation stood at Rs. 1.73 per share.
Singhe Hospitals posted revenue of Rs. 164 million as at 31 March 2014, up from Rs. 33.3 million in 2013. The company incurred finance costs of Rs. 51.9 million, up from a previous Rs. 50.6 million leading to a Rs. 131.6 million loss for the year, as compared with a loss of Rs. 107.9 million in 2013.
Notably, total comprehensive income for the year declined sharply to Rs. 37.1 million boosted significantly by a Rs. 94.5 million gain on revaluation of land and building in 2014. Basic loss per share stood at Rs. 4.69, against a previous Rs. 7.19 per share.

is it good to buy under 2/= if come ???

it will up Rs 3.30 or more...

It is very risky to play with IPO in bear market. I think it will drop to 2.00 soon.

@vimasanno wrote:it will up Rs 3.30 or more...

Don't buy SINH if u are planning for long term, definetly it will come below Rs 2.00 within a month.

I found this to be interesting.

http://lankanmarkets.blogspot.com/2015/06/health-is-profit-update-i.html

Customers : If you are looking for a hospital in Ratnapura look no further. 
Government : its high time you gave concessions to local hospitals that have advanced emergency treatment units& are owned by none other that Sri Lankans.
Investors : If you have not bought this share- which is of a company that is going to be the biggest blue chip in the nation, then yoi are about to miss out on this windfall of wealth I know I will receive.


HIGH TRADING CALIBRE

more like rubbish

@anges wrote:more like rubbish

Ooohh!  That may be what you eat but times are changing, KEEP UP OLD MAN!

Gems list should include this

Singhe hospitals 
Dialog
SLT
Colombo dock yard

HIGH TRADING CALIBRE

Any expert ideas

As I think now is the time to buy. See annual report.

Sinh is started

2.20 level tough.

Anilana hotels (ALHP) and Sinha hospitals are dangerous shares. Especially Anilana made huge losses to investors. We know the nature of owner so be careful with Anilana hotels.

99% of shares held by top 20.can move up easily

I collected nearly 400,000 shares this year at 1.7 per share. Today it pays off